Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 136(1): 62-5, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-14534613

RESUMO

Experiments on rats showed that pulse therapy with prednisolone (100 mg/kg intraperitoneally for 3 days) stimulated urinary excretion of hydroxyproline, increased the content of inorganic phosphorus, promoted the increase in the content of dienic conjugates and catalase activity, and decreased serum levels of MDA and ceruloplasmin. Ten-day treatment with dimephosphone (208 mg/kg) or xydiphone (45 mg/kg) after pulse therapy with prednisolone normalized urinary excretion of hydroxyproline and reduced the levels of dienic conjugates. Dimephosphone did not change, while xydiphone normalized the level of MDA decreased by prednisolone.


Assuntos
Ácido Etidrônico/farmacologia , Compostos Organofosforados/farmacologia , Prednisolona/farmacologia , Administração Oral , Animais , Cálcio/metabolismo , Catalase/metabolismo , Ceruloplasmina/metabolismo , Feminino , Glucocorticoides/metabolismo , Glucocorticoides/farmacologia , Hidroxiprolina/metabolismo , Hidroxiprolina/urina , Peroxidação de Lipídeos , Masculino , Malondialdeído/metabolismo , Fosfatos , Fósforo/sangue , Prednisolona/metabolismo , Ratos , Terapias em Estudo , Fatores de Tempo
2.
Eksp Klin Farmakol ; 66(1): 46-9, 2003.
Artigo em Russo | MEDLINE | ID: mdl-12683081

RESUMO

The parameters of mineral metabolism, a lipid peroxidation (LPO) process, and the efficacy of antioxidant enzyme preparations were studied in rats with an osteoporosis model induced by the administration of prednisolone in a daily dose of 100 mg/kg (i.p.) over 3 days, which is analogous to a pulsed therapy schedule in clinics. The treatment with glucocorticosteroid enhanced the excretion of hydroxyproline and inorganic phosphates with urine, increased the LPO rate and antioxidant activity of the blood serum, and decreases the level of ceruloplasmin and the catalase activity in the blood. A prophylactic treatment with dimephosphon (208 mg/kg, p.o.) and xydiphone (45 mg/kg, p.o.) prevents from the prednisolone-induced LPO activation. Dimephosphon, in contrast to xydiphone, also prevents from a prednisolone-induced increase in the excretion of hydroxyproline and inorganic phosphates with urine.


Assuntos
Anti-Inflamatórios não Esteroides/administração & dosagem , Ácido Etidrônico/administração & dosagem , Peroxidação de Lipídeos/efeitos dos fármacos , Compostos Organofosforados/administração & dosagem , Prednisolona/efeitos adversos , Animais , Cálcio/urina , Catalase/sangue , Feminino , Hidroxiprolina/urina , Masculino , Fosfatos/sangue , Fosfatos/urina , Prednisolona/administração & dosagem , Ratos
3.
Eksp Klin Farmakol ; 65(2): 40-3, 2002.
Artigo em Russo | MEDLINE | ID: mdl-12109292

RESUMO

Experiments in rats with an osteoporosis model induced by the chronic administration of prednisolone (50 mg/kg, p.o., over 14 days) showed that the drug differently affects the lipid peroxidation (LPO) rate and the antioxidant system activity. Xydiphone (45 mg/kg, p.o.) administered over 14 days exhibited a perooxidant action. Dimephosphon (208 mg/kg, p.o.) administered over the same period of time produced an antioxidant effect as manifested by a growth in the catalase activity, an increase in the content of ceruloplasmin and glutathione, and a decrease in the content of LPO products in the blood serum and liver tissues. The results of combined administration of prednisolone and phosphonates indicate good prospects of the dimephosphon treatment as a means of normalization of the LPO and antioxidant system functioning disturbed by prolonged use of glucocorticoids.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Antioxidantes/farmacologia , Ácido Etidrônico/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Compostos Organofosforados/farmacologia , Prednisolona/farmacologia , Animais , Anti-Inflamatórios não Esteroides/efeitos adversos , Antioxidantes/metabolismo , Interações Medicamentosas , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Osteoporose/sangue , Osteoporose/induzido quimicamente , Osteoporose/metabolismo , Oxirredução , Prednisolona/efeitos adversos , Ratos
4.
Eksp Klin Farmakol ; 65(5): 62-5, 2002.
Artigo em Russo | MEDLINE | ID: mdl-12596520

RESUMO

The efficacy of monophosphonate dimephosphon and diphosphonate xydiphon was compared by experiments in rats with an osteoporosis model induced by the chronic administration of prednisolone. The glucocorticosteroid decreased the total density of trabecules (in both bone and cartilage tissues) in histological micropreparations of lumbar vertebrae and reduced the total bone cell count and the calcium content in the bone tissue. Dimephosphon, administered on the prednisolone background over the same period of time, normalized the total relative density of trabecules (by increasing the cartilage content), the total bone cell count, and the calcium content. Under the same conditions, xydiphone normalized the total relative density of trabecules (by increasing the bone content), but did not influence the prednisolone-decreased content of cartilage, total cell count, and calcium content in the vertebrae. Thus, the test results reveal a significant advantage of dimephosphon over xydiphone.


Assuntos
Ácido Etidrônico/uso terapêutico , Glucocorticoides/toxicidade , Vértebras Lombares/patologia , Compostos Organofosforados/uso terapêutico , Osteoporose/tratamento farmacológico , Animais , Densidade Óssea/efeitos dos fármacos , Cálcio/metabolismo , Contagem de Células , Modelos Animais de Doenças , Vértebras Lombares/efeitos dos fármacos , Vértebras Lombares/metabolismo , Masculino , Osteoporose/induzido quimicamente , Osteoporose/metabolismo , Osteoporose/patologia , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...